This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2025 Dec 18;393(24):2486-2487.

doi: 10.1056/NEJMc2516172.

Allogeneic Beta Cells with No Immunosuppression. Reply

Per-Ola Carlsson¹, Tobias Deuse², Sonja Schrepfer³

Affiliations

Affiliations

¹ Uppsala University, Uppsala, Sweden.
² University of California, San Francisco, San Francisco.
³ Cedars-Sinai Medical Center, Los Angeles.

PMID: 41406458
DOI: 10.1056/NEJMc2516172

Comment

Allogeneic Beta Cells with No Immunosuppression. Reply

Per-Ola Carlsson et al. N Engl J Med. 2025.

. 2025 Dec 18;393(24):2486-2487.

doi: 10.1056/NEJMc2516172.

Authors

Per-Ola Carlsson¹, Tobias Deuse², Sonja Schrepfer³

Affiliations

¹ Uppsala University, Uppsala, Sweden.
² University of California, San Francisco, San Francisco.
³ Cedars-Sinai Medical Center, Los Angeles.

PMID: 41406458
DOI: 10.1056/NEJMc2516172

No abstract available

PubMed Disclaimer

Comment on

Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression.
Carlsson PO, Hu X, Scholz H, Ingvast S, Lundgren T, Scholz T, Eriksson O, Liss P, Yu D, Deuse T, Korsgren O, Schrepfer S. Carlsson PO, et al. N Engl J Med. 2025 Sep 4;393(9):887-894. doi: 10.1056/NEJMoa2503822. Epub 2025 Aug 4. N Engl J Med. 2025. PMID: 40757665

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.